Combination herbal medicines for the treatment of inflammatory bowel disorders
AssigneesEvinature Ltd., Sheba Impact Ltd.
InventorsShomron Silan Ben-Horin, Nir Salomon
Life of this patent
Estimating the term…
Abstract
The present invention is directed to combination therapies using compositions of Curcumin and Qing-Dai or extracts of plants producing thereof, and their clinical applications to the treatment of inflammatory conditions in general and to Inflammatory Bowel Diseases (IBD) in particular, including Crohn's disease, ulcerative colitis and related clinical conditions.
Claims32
A composition comprising a combination of Curcumin (Cur) and Qing-Dai (QD), or an extract of any part of a plant producing Cur or QD, wherein the Cur and the QD are present in a weight ratio ranging between 10:1 and about 1:10, respectively, and
- thereby providing an improved therapeutic effect relative to the effect of the same amounts of Cur and QD when used alone and/or a reduced adverse effect relative to the same amount of QD alone.
3-4. (canceled)
6-9. (canceled)
11-12. (canceled)
(canceled)
(canceled)
(canceled)
21-22. (canceled)
24-31. (canceled)
A method of preventing, ameliorating, or treating at least one symptom of a chronic systemic inflammatory disorder or condition (CID) in a subject suffering therefrom, comprising enteral administering to the subject a therapeutically effective amount of a composition or a dosage form comprising a combination of Cur and QD, or an extract of any part of a plant producing Cur or QD wherein the Cur and the QD are present at a weight ratio ranging between 10:1 and about 1:10 of the combination, respectively;
- the method optionally further comprising enteral administering to the same subject a composition or a dosage form comprising a therapeutically effective amount of Cur, said second administering of Cur being simultaneous with or in succession to the first administering of the Cur and QD combination.
33-34. (canceled)
(canceled)
(canceled)
46-55. (canceled)
Dependencies are inferred from the claim text.